Envista Holdings Corporation (NYSE:NVST) Receives Average Recommendation of “Hold” from Analysts

Envista Holdings Corporation (NYSE:NVST) has been assigned a consensus rating of “Hold” from the fifteen ratings firms that are currently covering the stock, MarketBeat.com reports. Nine investment analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $28.6667.

A number of analysts have commented on NVST shares. Citigroup started coverage on Envista in a report on Wednesday, April 15th. They set a “neutral” rating and a $29.00 price objective for the company. Zacks Research lowered Envista from a “strong-buy” rating to a “hold” rating in a report on Monday, April 6th. JPMorgan Chase & Co. boosted their price objective on Envista from $26.00 to $29.00 and gave the stock a “neutral” rating in a report on Thursday, May 7th. Morgan Stanley boosted their price objective on Envista from $19.00 to $21.00 and gave the stock an “equal weight” rating in a report on Friday, April 24th. Finally, Evercore reissued an “outperform” rating and set a $33.00 price objective on shares of Envista in a report on Thursday, May 7th.

Envista Stock Up 0.2%

NVST stock opened at $24.54 on Monday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.06 and a current ratio of 2.44. The stock’s 50 day simple moving average is $25.02 and its 200 day simple moving average is $24.71. The company has a market cap of $3.99 billion, a P/E ratio of 59.86, a price-to-earnings-growth ratio of 1.39 and a beta of 0.88. Envista has a fifty-two week low of $18.25 and a fifty-two week high of $30.42.

Envista (NYSE:NVST) last issued its quarterly earnings data on Wednesday, May 6th. The company reported $0.36 EPS for the quarter, topping analysts’ consensus estimates of $0.31 by $0.05. The firm had revenue of $705.50 million during the quarter, compared to analyst estimates of $680.04 million. Envista had a return on equity of 7.11% and a net margin of 2.41%.The company’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same period in the previous year, the company posted $0.24 EPS. Envista has set its FY 2026 guidance at 1.350-1.450 EPS. On average, research analysts expect that Envista will post 1.42 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Envista

Institutional investors have recently modified their holdings of the business. Caitong International Asset Management Co. Ltd grew its holdings in shares of Envista by 16,711.1% in the third quarter. Caitong International Asset Management Co. Ltd now owns 1,513 shares of the company’s stock valued at $31,000 after acquiring an additional 1,504 shares in the last quarter. Allworth Financial LP grew its holdings in shares of Envista by 75.4% in the fourth quarter. Allworth Financial LP now owns 1,805 shares of the company’s stock valued at $39,000 after acquiring an additional 776 shares in the last quarter. UMB Bank n.a. grew its holdings in shares of Envista by 46.1% in the fourth quarter. UMB Bank n.a. now owns 2,017 shares of the company’s stock valued at $44,000 after acquiring an additional 636 shares in the last quarter. IFP Advisors Inc grew its holdings in shares of Envista by 102.9% in the fourth quarter. IFP Advisors Inc now owns 2,112 shares of the company’s stock valued at $46,000 after acquiring an additional 1,071 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Envista by 73.1% in the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 2,248 shares of the company’s stock valued at $44,000 after acquiring an additional 949 shares in the last quarter.

Envista Company Profile

Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.

Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.